Skip to main content

Neuronetics, Inc.

STIM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001227636

In the last 90 days, Neuronetics, Inc. insiders filed 2 open-market purchases and 0 sales; 86 institutions reported holding it in 13F filings for Q2 2026, worth $48.4M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Neuronetics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of STIM: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders7776−1
Shares17.4M17.1M−306.3K (−1.8%)
Value$56.4M$54.4M−$2.03M (−3.6%)

New holders (11)

Institutions that held Neuronetics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to STIM in Q3 2022
InstitutionSharesValue% of portfolio
Kent Lake Capital LLC383,696$1.22M0.80%
Assenagon Asset Management S.A.261,838$833.0K0.00%
Divisadero Street Capital Management, LP194,844$620.0K0.69%
Parkman Healthcare Partners LLC85,866$273.0K0.08%
State of Wyoming44,102$140.0K0.07%
Walleye Capital LLC36,214$115.0K0.00%
Prudential Financial Inc14,200$45.0K0.00%
CWM, LLC12,931$41.0K0.00%
Baker Tilly Wealth Management, LLC12,624$40.0K0.01%
PDT Partners, LLC12,018$38.0K0.01%
Acadian Asset Management LLC3,686$11.0K0.00%

Sold out (12)

Institutions that held Neuronetics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.